Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2011-04-19
2011-04-19
Lucas, Zachariah (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S069100, C435S005000
Reexamination Certificate
active
07927793
ABSTRACT:
Host nucleic acids and host proteins that participate in viral infection, such as human immunodeficiency virus (HIV), influenza A, and Ebola virus, have been identified. Interfering with or disrupting the interaction between a host nucleic acid or host protein and a virus or viral protein confers an inhibition of or resistance to infection. Thus, interfering with such an interaction in a host subject can confer a therapeutic or prophylactic effect against a virus. The sequences identified can be used to identify agents that reduce or inhibit viral infection.
REFERENCES:
patent: 5616472 (1997-04-01), Choi et al.
patent: 5928881 (1999-07-01), Barnette et al.
patent: 6080576 (2000-06-01), Zambrowicz et al.
patent: 6136566 (2000-10-01), Sands et al.
patent: 6139833 (2000-10-01), Burgess et al.
patent: 6207371 (2001-03-01), Zambrowicz et al.
patent: 6218123 (2001-04-01), Nehls et al.
patent: 6436707 (2002-08-01), Zambrowicz et al.
patent: 6448000 (2002-09-01), Rubin et al.
patent: 2003/0166870 (2003-09-01), Wu et al.
patent: WO 97/45543 (1997-04-01), None
patent: WO 98/30716 (1998-07-01), None
patent: WO 01/83754 (2001-08-01), None
patent: WO 02/44321 (2002-06-01), None
patent: WO2005/092924 (2005-10-01), None
Hanna et al. (PNAS, May 2002, vol. 99, p. 7450-7454).
Blot et al. (Journal of Virology, Jun. 2003, vol. 77, p. 6931-6945).
Fridell, PNAS, 1996, vol. 93, p. 4421-4424.
Muzny et al. Accession No. AC 079383, 2000, p. 1-64.
Murray et al. Journal of Virology 2005, vol. 79. p. 11742-11751.
Froeyen et al., “RNA as a Target for Drug Design, the Example of Tat-TAR Interaction,”Curr. Top. Med. Chem. 2:1123-1145 (2002).
Gitlin et al., “Short Interfering RNA Confers Intracellular Antiviral Immunity in Human Cells,”Nature418:430-434 (2002).
Gulakowski et al., “A Semiautomated Multiparameter Approach for Anti-HIV Drug Screening,”J. Virol. Methods33:87-100 (1991).
Hata et al., “A Simple Purification and Fluorescent Assay Method of the Poliovirus 3C Protease Searching for Specific Inhibitors,”J. Virol. Methods. 84:117-126 (2000).
Kashani-Sabet, “Ribozyme Therapeutics,”JID Symposium Proceedings7:76-78 (2002).
Manetta et al., “Design and Implementation of a Particle Concentration Fluorescence Method for the Detection of HIV-1 Protease Inhibitors,”Anal. Biochem. 202(1):10-15 (1992).
Marschall et al., “Inhibition of Gene Expression with Ribozymes,”Cell Mol. Neurobiol. 14:523-538 (1994).
Scherr et al., “Gene Silencing Mediated by Small Interfering RNAs in Mammalian Cells,”Curr. Med. Chem. 10:245-256 (2003).
Singh et al., “The Complestatins as HIV-1 Integrase Inhibitors. Efficient Isolation, Structure Elucidation, and Inhibitory Activities of Isocomplestatin, Chloropeptin I, New Completatins A and B, and Acid-Hydrolysis Products of Chloropeptin I,”J. Natl. Prod. 64:874-882 (2001).
Ueda et al., “An In Vitro System for Screening Anti-Hepatitis B. Virus Drugs,”Virology169:213-216 (1989).
DesJarlais et al., “A Shape- and Chemistry-Based Docking Method and Its Use in the Design of HIV-1 Protease Inhibitors,”J. Comput. Aided Mol. Des. 8:231-242 (1994).
Argaet et al., “Dominant Selection of an Invariant T Cell Antigen Receptor in Response to Persistent Infection by Epstein-Barr Virus,”J. Exp. Med. 180:2335-2340, 1994.
Gavrilovskaya et al., “β3Integrins Mediate the Cellular Entry of Hantaviruses that Cause Respiratory Failure,”Proc. Natl. Acad. Sci. USA95:7074-7079, 1998.
Groh et al., “Costimulation of CD8 αβ T Cells by NKG2D via Engagement by MIC Induced on Virus-Infected Cells,”Nature Immunol. 2:255-260, 2001.
Blot et al., “Targeting of the human immunodeficiency virus type 1 envelope to the trans-Golgi network through binding to TIP47 is required for Env incorporation into virions and infectivity,”Journal of Virology, vol. 77, No. 12, pp. 6391-6945, 2003.
Lombardi et al., “Rab9 functions in transport between late endosomes and the trans Golgi network,”European Molecular Biology Organization Journal, vol. 12, No. 2, pp. 677-682, 1993.
Murray et al., “Rab9 GTPase is required for replication of human immunodeficiency virus type 1, filoviruses, and measles virus ,”American Society for Microbiology, vol. 79, No. 18, pp. 11742-11751, 2005.
Rodman et al., “Rab GTPases coordinate endocytosis,”Journal of Cell Science, vol. 113, No. 2, pp. 183-192, 2000.
Sieczkarski et al., “Dissecting virus entry via endocytosis,”Journal of General Virology, vol. 83, No. 7, pp. 1535-1545, 2002.
Van Der Sluijs et al., “Rab GTPases as regulators of transport through endosomes,”Protoplasma, vol. 210, Nos. 1-2, pp. 1-10, 1999.
Hodge Thomas W.
McDonald Natalie J.
Rubin Donald H.
Sanchez Anthony
Shaw Michael W.
Boesen Agnieszka
Klarquist & Sparkman, LLP
Lucas Zachariah
The United States of America as represented by the Department of
Vanderbilt University
LandOfFree
Cell lines and host nucleic acid sequences related to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cell lines and host nucleic acid sequences related to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell lines and host nucleic acid sequences related to... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2651938